Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Blue Owl Capital Holdings LP Stock Portfolio

$500Million– No. of Holdings #45

Blue Owl Capital Holdings LP Performance:
2024 Q1: 8.35%YTD: 8.35%2023: 34.9%

Performance for 2024 Q1 is 8.35%, and YTD is 8.35%, and 2023 is 34.9%.

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $500.6 Millions as of 31 Mar, 2024.

The top stock holdings of Blue Owl Capital Holdings LP are HOOD, CGEM, PLRX. The fund has invested 10.8% of it's portfolio in ROBINHOOD MKTS INC and 10% of portfolio in CULLINAN ONCOLOGY INC.

The fund managers got completely rid off BLUEPRINT MEDICINES CORP (BPMC), ORCHARD THERAPEUTICS PLC (ORTX) and FREELINE THERAPEUTICS HLDGS (FRLN) stocks. They significantly reduced their stock positions in TOAST INC (TOST), SYROS PHARMACEUTICALS INC (SYRS) and KEROS THERAPEUTICS INC (KROS). Blue Owl Capital Holdings LP opened new stock positions in EVERCOMMERCE INC (EVCM), AQUESTIVE THERAPEUTICS INC (AQST) and MADRIGAL PHARMACEUTICALS INC (MDGL). The fund showed a lot of confidence in some stocks as they added substantially to STARWOOD PROPERTY TRUST (BRZE), SAGIMET BIOSCIENCES INC and GERON CORPORATION (UBER).
Blue Owl Capital Holdings LP Equity Portfolio Value
Last Reported on: 15 May, 2024

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 8.35% in the last quarter. In trailing 12 months, it's portfolio return was 35.1%.

New Buys

Ticker$ Bought
evercommerce inc15,467,000
aquestive therapeutics inc3,727,500
madrigal pharmaceuticals inc3,556,710
snowflake inc1,263,550
gitlab, inc1,207,570
enliven therapeutics inc439,750
precision biosciences inc274,183

New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker% Inc.
starwood property trust555
sagimet biosciences inc371
geron corporation286
engene holdings inc99.34
ikena oncology inc99.18
immunovant inc66.67
moonlake immunotherapeutics53.85
direxion shs etf tr44.12

Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
toast inc-94.52
syros pharmaceuticals inc-77.17
keros therapeutics inc-51.04
cullinan oncology inc-14.47
mineralys therapeutics inc-4.8

Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
orchard therapeutics plc-2,631,440
freeline therapeutics hldgs-551,986
blueprint medicines corp-6,630,950
precision biosciences inc-221,420
mirum pharmaceuticals inc-295,584

Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 42.5% of it's holdings in Healthcare sector.

Sector%
Healthcare42.5
Others38
Technology19.3

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 13.6% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED38
SMALL-CAP32
LARGE-CAP13.6
MICRO-CAP10.7
MID-CAP5.6

Stocks belong to which Index?

About 39.5% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others60.5
RUSSELL 200039.5
Top 5 Winners (%)%
TOST
toast inc
142.2 %
BDTX
black diamond therapeutics i
80.4 %
INZY
inozyme pharma inc
79.8 %
CGEM
cullinan oncology inc
66.9 %
AQST
aquestive therapeutics inc
58.4 %
Top 5 Winners ($)$
CGEM
cullinan oncology inc
23.3 M
LRMR
larimar therapeutics inc
10.3 M
TOST
toast inc
8.6 M
KROS
keros therapeutics inc
8.1 M
INZY
inozyme pharma inc
4.3 M
Top 5 Losers (%)%
UBER
geron corporation
-82.0 %
RPTX
repare therapeutics inc
-35.5 %
BRZE
starwood property trust
-30.2 %
RLYB
rallybio corp
-22.6 %
GOCO
gohealth inc
-21.2 %
Top 5 Losers ($)$
PLRX
pliant therapeutics inc
-9.6 M
RPTX
repare therapeutics inc
-8.1 M
IKNA
ikena oncology inc
-1.1 M
BRZE
starwood property trust
-1.0 M
MLTX
moonlake immunotherapeutics
-0.8 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 45 stocks in it's portfolio. About 69.7% of the portfolio is in top 10 stocks. PLRX proved to be the most loss making stock for the portfolio. CGEM was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions